• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海湾合作委员会国家对药品和医疗用品的团购。

Group purchasing of pharmaceuticals and medical supplies by the Gulf Cooperation Council states.

作者信息

Khoja T A M, Bawazir S A

机构信息

Executive Office of the GCC States for Health Ministers, Riyadh, Saudi Arabia.

出版信息

East Mediterr Health J. 2005 Jan-Mar;11(1-2):217-25.

PMID:16532691
Abstract

An important issue in health care today is the cost of essential pharmaceuticals and medical supplies. To control the increase of health care expenses, in 1976 the Gulf Cooperation Council states began to study the idea of establishing a group purchasing programme for pharmaceuticals and medical supplies. This paper demonstrates the elements of the programme, how it works, what obstacles it faces and how other countries can profit from this experience. It also discusses the future of the group purchasing programme in the light of globalization and how the international changes under the World Trade Organization agreements will affect the programme in future.

摘要

当今医疗保健领域的一个重要问题是基本药品和医疗用品的成本。为控制医疗保健费用的增长,海湾合作委员会国家于1976年开始研究为药品和医疗用品建立集团采购计划的想法。本文阐述了该计划的要素、运作方式、面临的障碍以及其他国家如何从这一经验中获益。它还根据全球化探讨了集团采购计划的未来,以及世界贸易组织协议下的国际变化将如何在未来影响该计划。

相似文献

1
Group purchasing of pharmaceuticals and medical supplies by the Gulf Cooperation Council states.海湾合作委员会国家对药品和医疗用品的团购。
East Mediterr Health J. 2005 Jan-Mar;11(1-2):217-25.
2
The Arabian Gulf University College of Medicine and Medical Sciences: a successful model of a multinational medical school.阿拉伯海湾大学医学与医学科学学院:一所跨国医学院的成功典范。
Acad Med. 2006 Dec;81(12):1085-90. doi: 10.1097/01.ACM.0000246680.82786.76.
3
A system for collecting vital statistics in Gulf Cooperation Council countries.海湾合作委员会国家的人口动态统计数据收集系统。
Popul Bull ESCWA. 1989(35-37):43-97.
4
Systematic thematic review of e-health research in the Gulf Cooperation Council (Arabian Gulf): Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates.系统主题评价海湾合作委员会(阿拉伯湾)的电子健康研究:巴林、科威特、阿曼、卡塔尔、沙特阿拉伯和阿拉伯联合酋长国。
J Telemed Telecare. 2017 May;23(4):452-459. doi: 10.1177/1357633X16647894. Epub 2016 May 28.
5
Continuous quality improvement. A proposal for Arabian Gulf Medical Associations.持续质量改进。给阿拉伯湾医学协会的一项提议。
Saudi Med J. 2000 Feb;21(2):135-7.
6
Quantity and quality of research from the Gulf Corporation Council countries.海湾合作委员会国家的研究数量与质量。
Saudi Med J. 2001 Nov;22(11):1040-1.
7
Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).参与透析结果与实践模式研究第5阶段(2012 - 2015年)的海湾合作委员会国家血液透析患者的血液透析治疗、透析剂量达成情况及血管通路类型
Saudi J Kidney Dis Transpl. 2016 Nov;27(6 Suppl 1):S42-50. doi: 10.4103/1319-2442.194889.
8
Association of reproductive factors with the incidence of breast cancer in Gulf Cooperation Council countries.海湾合作委员会国家生殖因素与乳腺癌发病率的关联
East Mediterr Health J. 2009 May-Jun;15(3):612-21.
9
Tackling cancer control in the Gulf Cooperation Council Countries.应对海湾合作委员会国家的癌症控制问题。
Lancet Oncol. 2015 May;16(5):e246-57. doi: 10.1016/S1470-2045(15)70034-3.
10
Undergraduate medical education in the Gulf Cooperation Council: a multi-countries study (Part 2).海湾合作委员会国家的本科医学教育:多国研究(第二部分)。
Med Teach. 2010;32(4):290-5. doi: 10.3109/01421591003673730.

引用本文的文献

1
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally.激励新型抗生素和诊断试剂进入市场的定价、采购和报销政策:全球 10 个国家的经验教训。
Appl Health Econ Health Policy. 2024 Sep;22(5):629-652. doi: 10.1007/s40258-024-00888-y. Epub 2024 Jun 5.
2
European collaborations on medicine and vaccine procurement.欧洲在医学和疫苗采购方面的合作。
Bull World Health Organ. 2021 Oct 1;99(10):715-721. doi: 10.2471/BLT.21.285761. Epub 2021 Aug 20.
3
Cross-border Collaboration to Improve Access to Medicine: Association of Southeast Asian Nations Perspective.
跨境合作以改善药品可及性:东南亚国家联盟视角
J Epidemiol Glob Health. 2019 Jun;9(2):93-97. doi: 10.2991/jegh.k.190506.001.
4
Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries.供应链和采购流程的变革是否能节省成本并提高药品、疫苗或健康产品的可及性?对低收入和中等收入国家证据的系统评价。
BMJ Glob Health. 2017 Apr 13;2(2):e000243. doi: 10.1136/bmjgh-2016-000243. eCollection 2017.
5
Pharmacoeconomic analysis in Saudi Arabia: an overdue agenda item for action.沙特阿拉伯的药物经济学分析:一项亟待开展的议程项目。
Ann Saudi Med. 2011 Jul-Aug;31(4):335-41. doi: 10.4103/0256-4947.83201.